No Detail Found!

Expression of Thymidylate Synthase and Thymidine Phosphorylase as prognostic markers in advanced esophageal squamous cell carcinoma.

Author(s)
Sepideh Arbabi Bidgoli Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, P.O. Box 14155-645 1, Iran; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Islamic Azad University, Tehran, Iran
Minaee Bagher Department of Anatomy and Embryology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Hosein Ghahremani Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, P.O. Box 14155-645 1, Iran
Mansoor Djamali Zavarhei Department of Pathology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Seyed Nasser Ostad Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, P.O. Box 14155-645 1, Iran
F. Shamileh Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, P.O. Box 14155-645 1, Iran
E. Azizi Molecular Research Laboratory, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Abstract
There are controversial data regarding the correlation between gene expression of Thymidylate Synthase (TS) and Thymidine Phosphorylase (TP) with response to chemotherapy and patients’ survival in gastrointestinal malignancies. Therefore, the prognostic role of TS and TP in GI malignancies and in particular, the Esophageal Squamous Cell Carcinoma (ESCC) needs to be more clarified. The TS and TP status in ESCC was determined and correlated molecular alterations with clinicopathological findings. Tumor samples of 30 surgically resected patients were analyzed by immunohistochemical techniques using primary antibodies for TS and TP and Dako labeled Streptavidin-Biotin’ 2 (LSAB2) System detection kit. TS and TP were positive in 63.3 and 89.7% of tumor samples, respectively. Unlike TS, expression of TP was correlated with tumor size (p = 0.013). Although the most prevalent immunophenotype was TS’/TP’ (16/30; 53.33%) but the other immunophenotype (TS-/TP’; 10/30; 33.32%) also showed significant relationship with lymphatic invasion (p = 0.035) and histological differentiation (p = 0.001). Despite low number of metastatic cases, four cases out of five had positive expression of both TS and TP in their primary tumor samples. The high TP expression (89.1%) and its established role in tumor angiogenesis could be the reason for its correlation with tumor size and also progression of early stage of ESCC to the advanced stage. Based on present data as well as others, the overexpression of both TS and TP would indicate a poor prognosis for patients with ESCC. On the other hand, our data showed that 36.7 and 10.3% of patients were TS and TP negative, respectively, that obviously affect their response to 5-FU based chemotherapy. In conclusion, the present data showed the importance of TS and TP as valuable prognostic markers that are in correlation with clinicopathological findings.
Publication Details
Page(s) 104-111
DOI DOI not available
Published Journal: International Journal of Pharmacology, Volume: 1, Issue: 2, Year: 2005

Request the full text from PASTIC

0

Citations

0

Downloads

103

Views